Daxor Story

DXR -- USA Stock

USD 12.85 0.21 1.61%

Macroaxis Story

Daxor Price to Sales Ratio is relatively stable at the moment as compared to the past year. Daxor reported last year Price to Sales Ratio of 23.89. As of 11/27/2020, Sales per Share is likely to grow to 0.32, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (11 M). While many traders are getting carried away by overanalyzing financial services space, it is reasonable to sum up Daxor. We will analyze why it could be a much better year for Daxor shareholders. Here I will also expose some primary fundamental factors affecting Daxor's services, and outline how it will impact the outlook for investors this year.

Published over a month ago

View all stories for Daxor | View All Stories

Is Daxor (NYSEMKT:DXR) ripping up retail investors?

This firm reported the last year's revenue of 306.17 K. Reported Net Loss for the year was (4.48 M) with profit before taxes, overhead, and interest of 380.14 K. About 70.0% of the company shares are held by company insiders. The book value of Daxor was currently reported as 2.87. The company has Price/Earnings (P/E) ratio of 176.69. Daxor recorded a loss per share of 1.15. The entity last dividend was issued on the 5th of January 2018.

How important is Daxor's Liquidity

Daxor financial leverage refers to using borrowed capital as a funding source to finance Daxor ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Daxor financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Daxor's total debt and its cash.

How Daxor utilizes its cash?

To perform a cash flow analysis of Daxor, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Daxor is receiving and how much cash it distributes out in a given period. The Daxor cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Daxor Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. Daxor reported last year Net Cash Flow from Operations of (5.86 Million)

What did Daxor file with SEC?

The SEC filings are financial statements or other formal documents of Daxor that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database. Please check here for more information.

Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Daxor shareholders may or may not be submitted as SEC does not always require it.

5th of October 2020

Financial Statements and Exhibits. Other Events

View

A Deeper Perspective

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Daxor has an asset utilization ratio of 0.36 percent. This connotes that the company is making $0.003572 for each dollar of assets. An increasing asset utilization means that Daxor is more efficient with each dollar of assets it utilizes for everyday operations.

Will price continue to spike in December 2020?

The mean deviation is down to 1.46 as of today. Daxor exhibits very low volatility with skewness of -0.01 and kurtosis of -0.15. However, we advise investors to further study Daxor technical indicators to make sure all market info is available and is reliable.

Our Takeaway on Daxor Investment

While other entities in the asset management industry are either recovering or due for a correction, Daxor may not be performing as strong as the other in terms of long-term growth potentials. To conclude, as of the 27th of November 2020, our research shows that Daxor is a rather not too volatile investment opportunity with a very low probability of distress in the next two years. From a slightly different view, the entity currently appears to be overvalued. Our present 30 days recommendation on the enterprise is Cautious Hold.

About Contributor

Raphi Shpitalnik is a Junior Member of Macroaxs Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time base at the beginning of the pandemic and eventually acquired a real test for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Daxor. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC